Taken together, these results suggest that CRCs with VEGFA gene amplification or Chr6 polysomy are associated with reduced PD-1-positive tumor infiltrating lymphocytes and PD-L1 stromal expression. This evidence concerns the gene VEGFA and neoplasm.